Commonwealth Equity Services »

Immix Biopharma shares owned by Commonwealth Equity Services

Quarter-by-quarter ownership of Immix Biopharma (IMMX) shares owned by Commonwealth Equity Services from 13F filings

Historical chart of Commonwealth Equity Services investment in Immix Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Immix Biopharma held by Commonwealth Equity Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immix Biopharma by Commonwealth Equity Services

Quarter filed Position value Share count Share price at filing
2023-12-31 $196k 28k 6.93
2023-09-30 $99k 29k 3.43
2023-06-30 $61k 23k 2.67

More positions owned by Commonwealth Equity Services

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Ishares Tr Rus 1000 Grw Etf (IWF)
NVIDIA Corporation (NVDA)
Vanguard Index Fds Total Stk Mkt (VTI)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Value Etf (VTV)
Vanguard Specialized Funds Div App Etf (VIG)

View all positions for Commonwealth Equity Services

Top funds holding Immix Biopharma

Vanguard Group
Private Advisor
Imprint Wealth
Commonwealth Equity Services
Tritonpoint Wealth
Moss Adams Wealth Advisors
Tocqueville Asset Management
Jump Financial
Jane Street
Dimensional Fund Advisors
InterOcean Capital Group
Old National Trust Company
Bank Of Montreal
UBS Group
Bank of America Corporation

View all funds holding Immix Biopharma